Conmed (NASDAQ: CNMD) reported Q3 EPS of $0.41, $0.01 better than the analyst estimate of $0.40. Revenue for the quarter came in at $184.8 million versus the consensus estimate of $180.13 million.

Conmed reaffirmed FY2016 guidance.

For earnings history and earnings-related data on Conmed (CNMD) click here.